Search Results (45)

In agriculture, soil amendments like compost, manure, superabsorbent polymers (SAP) and biochar (BC) are already in use to mitigate the effects of water shortage and to obtain a higher yield and survivability. The present study focuses on the impact of BC and SAP under moderate and reduced soil water content (SWC) on the physiological and biochemical response of Chenopodium quinoa Willd. (cv. UDEC-5), a naturally drought-resistant and strategic crop in arid regions, with the aim of further improving its resilience and biomass production. Plants were grown in the presence or absence (control) of SAP (1% or 0.1% g/100 g SAP) or BC (3% g/100 g BC) by taking into account the smallest possible amount of irrigation necessary for optimal growth of the control. Sixty-five days after sowing, the reduced watering approaches started. The irrigation amount was reduced slowly until plants without any amendment showed a significant reduction in CO₂/H₂O gas exchange and further significant changes in 23 morphological, physiological and biochemical symptoms of water shortage. Each amendment already caused individual plant response in wet conditions: The soil amendments of SAP (1% and 0.1%) and BC had no significant effect on biomass production but caused changes in PS I (portion of oxidized and open centers in PS I), the C/N ratio and N content. The addition of SAP (0.1% and 1%) led to a decrease in gH⁺, ECStmAu ^× gH⁺, R_D, R_L, the C_i/C_atm ratio and ETR/A_gross ratio and to an increase in water use efficiency (WUE), especially in the 0.1% SAP treatment. In moderate conditions, 0.1% SAP and 3% BC caused a significant increase in both the LOP and C/N ratio. In the moderate treatments, the application of 0.1% SAP promoted an increased A_net, while 3% BC promoted a significant reduction in malondialdehyde (MDA). The results of the present quinoa experiment indicate the drought avoidance mechanism of the control under low SWC. The reduced transpiration led to increased WUE due to the efficient use of the substomatal CO₂ reservoir under low C_s and low E. It could also be confirmed that quinoa plants balanced low soil water potential by the accumulation of compatible solutes to lower the LWP and LOP. Drought led, especially in leaves in the 1% SAP treatment, to significant reductions in CO₂/H₂O gas exchange (A_net, R_D), decreases in Y (II) and ETR in PS II, and an increase in the ETR/A ratio and over-reduced centers in PS I, pointing to an increased appearance of reactive oxygen species (ROS) in the chloroplasts. The latter change was indicated by higher levels of lipid peroxidation (MDA). It could be shown that the response of the test species Chenopodium quinoa to the addition of BC and SAP proved to be highly adaptable. The plant reacted in a very coordinated and specific way to both the danger of oversupply of SAP soil amendments under water shortage conditions and an effective adaptation to a limited water supply with 3% BC and 0.1% SAP by increasing WUE and proline content. However, BC also had a mitigating effect on the level of reactive oxygen species (ROS). It can be assumed that this effect is based on a more plant-compatible, less one-sided ion composition of BC. The results presented indicate that SAP and BC can have an impact on the water and nutrient accessibility for plants. Therefore, optimal biomass production and plant response can only be reached if plant soil interactions and competition between SAP, BC and the plant roots are taken into account when planning for climate-resilient, water-saving agriculture. Full article

Background/Objectives: The growing threat posed by antimicrobial resistance to worldwide public health highlights the urgent need not only for new anti-infective candidates, but also for innovative formulation strategies capable of mediating effective delivery of anti-infective compounds. The current study, therefore, aimed to demonstrate the feasibility of formulating lipid-polymer hybrid nanoparticles (LPHNPs) with dual loading of both core and shell compartments for combination anti-infective delivery. Methods: LPHNPs containing the antibiotic cefotaxime within a chitosan polymer core and the novel antimicrobial peptide RN7IN6 within a bacteria-mimicking lipid shell were produced by microfluidic mixing, and optimized with respect to parameters including total flow rate, flow rate ratio, and lipid concentration. Minimum inhibitory concentrations of cefotaxime and RN7IN6 co-incorporated in LPHNPs were assessed as a preliminary indicator of antibacterial efficacy. Results: Uniformly nanosized LPHNPs were produced, with maximized loading of cefotaxime and RN7IN6 within particle cores and shells, respectively. Empty LPHNPs showed an appreciable antibacterial activity, particularly against the Gram-negative bacterium Escherichia coli, while RN7IN6 was indicated to enhance cefotaxime activity against E. coli when both actives were incorporated in LPHNPs. Conclusions: The current findings clearly demonstrate the feasibility of formulating LPHNPs for core-shell co-encapsulation and delivery of anti-infectives. The promising antibacterial efficacy of co-loaded LPHNPs warrants further in-depth investigation to determine the extent of co-loaded LPHNP applications as combination anti-infective delivery platforms. Full article

Luteolin is a naturally occurring flavonoid with growing interest for its senolytic properties. However, its poor water solubility and low bioavailability limit clinical application. This study aimed to develop and compare two types of nanocarriers, liposomes and polymeric nanoparticles, for the efficient delivery of luteolin in senolytic therapies. Liposomes with luteolin were prepared using the lipid film hydration method, followed by sonication and extrusion. Polymeric nanoparticles were developed via the nanoprecipitation method using pullulan acetate, a hydrophobic derivative obtained by chemical functionalization of pullulan. Pullulan was biosynthesized over 72 h using the microorganism Aureobasidium pullulans ICCF 36 (from CMII–INCDCF-ICCF). The formulation used a polymer-to-luteolin ratio of 10:1 (g/g) and Pluronic F127 as a stabilizer. Nanoprecipitation was carried out under controlled conditions: stirring at 700 rpm and dropwise addition at 0.5 mL/min. Luteolin was successfully encapsulated in both delivery systems. Liposomes showed an encapsulation efficiency of 85.07 ± 0.09% and nanoscale diameter. Polymeric nanoparticles demonstrated an encapsulation efficiency of 74.87 ± 0.05%, nanometric size and a formulation yield of 73.29 ± 0.09%. Both liposomal and polymeric nanoparticle systems effectively encapsulated luteolin, with high efficiency and yield. The formulations present promising potential for use in senolytic therapies, targeting age-related cellular dysfunction. Further studies will assess their release kinetics, biological activity, and senolytic effects in vitro and in vivo. Full article

Nisin, a food preservative lantibiotic produced by Lactococcus lactis, exhibits potent antimicrobial activity against a wide range of Gram-positive pathogens, including antibiotic-resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA). This study explores the development of a novel nano drug delivery platform comprising nisin-loaded niosomes, formulated via microfluidic mixing, and integrated into fast-dissolving oral films for targeted buccal administration. Microfluidic synthesis enabled the precise control of critical parameters including the flow rate ratio, surfactant composition, and lipid concentration, resulting in uniform niosomal vesicles with optimal size distribution (100–200 nm), low polydispersity index, and high encapsulation efficiency. Span 40 and Span 60 were employed as non-ionic surfactants, stabilized with cholesterol to improve bilayer rigidity and drug retention. The encapsulated nisin demonstrated improved physicochemical stability over time and protection against proteolytic degradation, thus preserving its antimicrobial potency. The niosomal suspensions were subsequently incorporated into polymer-based oral films as a final dosage form composed of polyvinyl alcohol (PVA) as the primary film-forming polymer, polyethylene glycol 400 (PEG400) as a plasticizer, and sucralose and mint as a sweetener and flavoring agent, respectively. A disintegrant was added to accelerate film dissolution in the oral cavity, facilitating the rapid release of niosomal nisin. The films were cast and evaluated for thickness uniformity, mechanical properties, disintegration time, surface morphology, and drug content uniformity. The dried films exhibited desirable flexibility, rapid disintegration (<30 s), and consistent distribution of nisin-loaded vesicles. In vitro antimicrobial assays confirmed that the bioactivity of nisin was retained post-formulation, showing effective inhibition zones (16 mm) against Bacillus subtilis. This delivery system offers a promising platform for localized antimicrobial therapy in the oral cavity, potentially aiding in the treatment of dental plaque, oral infections, and periodontal diseases. Overall, the integration of microfluidic-synthesized nisin niosomes into oral films presents a novel, non-invasive strategy for enhancing the stability and therapeutic efficacy of peptide-based drugs in mucosal environments. Physicochemical characterization of the niosomes and niosome films was performed using Fourier-transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) to evaluate thermal stability and scanning electron microscopy (SEM) to assess surface morphology. In vitro peptide release studies demonstrated sustained release from both niosomal suspensions and film matrices, and the resulting data were further fitted to established kinetic models to elucidate the underlying drug release mechanisms. This delivery system offers a promising platform for localized antimicrobial therapy in the oral cavity, potentially aiding in the treatment of dental plaque, oral infections, and periodontal diseases. Overall, the integration of microfluidic-synthesized nisin niosomes into oral films presents a novel, non-invasive strategy for enhancing the stability and therapeutic efficacy of peptide-based drugs in mucosal environments. Full article

The aim of this study was to evaluate the potential of black cumin essential oils to reduce the degradation of rapeseed oil during heating. Rapeseed oil was heated without addition and with the addition of black cumin essential oil (200 ppm, 500 ppm, and 1000 ppm), and with synthetic antioxidant TBHQ (200 ppm). The heating was carried out at 170 °C ± 10 °C for 6 h, in a deep-fat heating model. In all samples, changes in fatty acid profile, lipid-nutritional quality indices (PUFA/SFA ratio, atherogenicity index, thrombogenicity index, and hypocholesterolemic/hypercholesterolemic ratio), tocopherol and phytosterol content, total polar compound content, and triacylglycerol polymers were determined. The heating process led to oil degradation, which depended on the amount and type of additive used. The greatest changes were observed in the control sample (without additives). The addition of TBHQ or 200 ppm of black cumin essential oil reduced the adverse transformations to a similar level. Higher additions of black cumin essential oil led to a significant improvement in the quality of heated oils. The best results were obtained with the addition of 1000 ppm of black cumin essential oil. Full article

Background/Objectives: This research focuses on the development and optimization of polymer–lipid hybrid nanoparticles (PLHNs) using two grades of mPEG-PCL co-polymers in combination with DPPC and lecithin to address the biopharmaceutical challenges of acalabrutinib (ACP), a selective treatment for different hematological malignancies. Methods: Variations in the mPEG-to-ε-caprolactone ratio influenced both the molecular weight (Mw) of the synthesized co-polymers and their aqueous phase affinity. The ACP-loaded PLHNs (ACP-PLHNs) were optimized using a circumscribed central composite design. The in vivo studies were performed in Wistar rats. Results: The lipophilic mPEG-PCL (Mw = 9817.67 Da) resulted in PLHNs with a particle size of 155.91 nm and 40.08% drug loading, while the hydrophilic mPEG-PCL (Mw = 23,615.84 Da) yielded PLHNs with a relatively larger size (223.46 nm) and relatively higher drug loading (46.59%). The drug release profiles were polymer-grade dependent: lipophilic ACP-PLHNs (lACP-PLHNs) sustained release up to 30 h in pH 7.2 buffer, while hydrophilic ACP-PLHNs (hACP-PLHNs) completed release within 24 h. Stability studies showed greater stability for lACP-PLHNs, likely due to reduced molecular rearrangement from the chemically stable lipophilic co-polymer. Conclusions: Oral administration of both formulations exhibited a 2-fold (p < 0.001) improvement in the C_max and AUC_0-tlast and a 3.9-fold (p < 0.001) increase in the relatively oral bioavailability compared to the conventional ACP suspension in male wistar rats. Full article

Municipal wastewater treatment plants produce vast amounts of sewage sludge as waste, with more than 80% dewatered sludge (DS). DS is a polymer-based sludge containing flocculant and extracellular polymeric substances, including lipids. Lipids can be converted into biodiesel as an alternative energy that reduces dependency on fossil fuels while helping cities manage waste more sustainably. Past studies explored the potential of lipids from various sewage sludges in biodiesel production. However, the potential of DS remains largely unexplored. This study evaluates the lipid extracted from DS and the potential of its fatty acid methyl ester (FAME) to be used as biodiesel. Lipid extraction was conducted under varying parameters, including temperatures of 70, 80, and 90 °C, extraction time of 2, 4, 6, and 8 h, and sludge-to-solvent (S/L) ratios of 0.05, 0.075, 0.1, 0.125, 0.15, and 0.175 g/mL. The optimal extraction conditions of 70 °C for 4 h at S/L of 0.175 g/mL yielded 1.71 ± 0.10% lipid. FTIR and TGA revealed that the DS lipids contain triglycerides, fatty acids, glycerol, and proteins. Transesterification of DS lipids produced DS FAME with a fatty acid profile ranging from C4:0 to C22:0. The evaluation of DS FAME revealed a high ester content (94.7%) of fatty acids ranging from C14:0 to C24:1, surpassing the minimum standard of 90% for biodiesel. The elevated proportion of unsaturated fatty acids in DS FAME is expected to result in a low melting point, reducing the solidifying effect and enhancing its performance as biodiesel. Full article

Background/Objectives: Following tooth extraction, resveratrol (RSV) can support healing by reducing inflammation and microbial risks, though its poor solubility limits its effectiveness. This study aims to develop a solid nanocomposite by embedding RSV in lipid nanoparticles (mLNP) within a hydrophilic matrix, to the scope of improving local delivery and enhancing healing. Hydroxyapatite (HXA), often used as a bone substitute, was added to prevent post-extraction alveolus volume reduction. Methods: The mLNP-RSV dispersion was mixed with seven different polymers in various mLNP/polymer ratios. Following freeze-drying, the powders were redispersed, and the resulting dispersions were tested by DLS experiments. Then, the best two nanocomposites underwent extensive characterization by SEM, XRD, FTIR, Raman spectroscopy, and thermal analysis as well as in vitro partitioning studies aimed at verifying their ability to yield the mLNP-RSV from the hydrophilic matrix to a lipophilic tissue. The characterizations led to identify the best nanocomposite, which was further combined with HXA to obtain hybrid nanocomposites, further evaluated as pharmaceutical powders or in form of mini-tablets. Results: PEG-based nanocomposites emerged as optimal and, following HXA insertion, the resulting powders revealed adequate bulk properties, making them useful as a pharmaceutical intermediate to produce ≈59 mm³ mini-tablets, compliant with the post-extraction socket. Moreover, they were proven ex vivo to be able to promote RSV and GA accumulation into the buccal tissue over time. Conclusions: The here-proposed mini-tablet offers an innovative therapeutic approach for alveolar wound healing promotion as they led to a standardized dose administration, while being handy and stable in terms of physical solid identity as long as it takes to suture the wound. Full article

Background. Lipid–polymer hybrid nanoparticles (LPHNPs) offer a promising method for delivering methylprednisolone (MePD) to treat lung inflammation, addressing aggregation issues seen with polymer-only formulations. Objectives. This study aimed to develop LPHNPs for MePD delivery, assessing their physicochemical properties, drug loading, cytocompatibility, and release profiles, ultimately enabling inhalable microparticle-based powder. Methods. The nanoparticles were formulated using α,β-poly(N-2-hydroxyethyl)-DL-aspartamide-g-Rhodamine B-g-poly(lactic acid) (PHEA-g-RhB-g-PLA) and phospholipids DPPC, DOTAP, and DSPE-PEG2000 in a 45:30:25 weight ratio. Their size, redispersion after freeze-drying, drug loading (DL%), and controlled release were evaluated. Cytocompatibility was assessed on 16-HBE cell lines, measuring anti-inflammatory effects via IL-6 and IL-8 levels. Spray drying was optimized to produce microparticles using mannitol (MAN), leucine (LEU), and N-acetylcysteine (NAC). Results. The nanoparticles had a size of 186 nm and a DL% of 2.9% for MePD. They showed good cytocompatibility, significantly reducing IL-6 and IL-8 levels. Spray drying yielded microparticles with a fine particle fraction (FPF) of 62.3% and a mass median aerodynamic diameter (MMAD) of 3.9 µm. Inclusion of LPHNPs@MePD (0.25% w/v) resulted in FPF and MMAD values of 56.7% and 4.4 µm. In conclusion, this study described the production of novel inhalable powders as carriers for MePD-loaded nanostructures with favorable physicochemical properties, cytocompatibility, and promising aerosol performance, indicating their potential as an effective inhalable therapy for lung inflammation with corticosteroids, especially for treating chronic diseases. Full article

Carob (Ceratonia siliqua) seeds are rich in diverse bioactive compounds, including galactomannan, β-sitosterol, unsaturated fatty acids and proteins with bioactive peptides in their sequence. This study delineates the compositional characterization of six carob seed flour types derived from different production processes, providing valuable insights for designing tailored nutraceutical products based on desired bioactive compound profiles. Our analysis indicated that a higher purity of galactomannan resulted in a greater mannose/galactose ratio, which increased the linearity of the galactomannan polymer and could enhance interchain interaction, thereby increasing aggregation capacity. A higher viscosity could potentially increase the capacity of galactomannan to create satiety and lower cholesterol levels. Among the different tested flours, those whose main compound was the endosperm were optimal for containing high galactomannan content, whereas those derived from the germ were ideal for having high concentrations of fatty acids (i.e., oleic and linoleic acids) and β-sitosterol. The presence of these lipids in carob flours could offer cardiovascular and metabolic health benefits, contributing synergistically. Additionally, flours that contain the germ have beneficial peptides included in proteins like glycinin and conglutin with potential anticholesterolemic and antidiabetic properties. This work provides different methods for obtaining carob flours rich in bioactive compounds, offering the nutraceutical industry a framework to select the best option for industrial-scale production. Full article

Dewatered sludge (DS) is a sewage sludge with a unique property due to extracellular polymeric substances (EPSs) and polymer flocculants. These components form a stable 3D polymer network to increase dewatering efficiency, leaving behind valuable materials such as lipids. This article explored the influences of DS particle size on lipid yield and the effects of extraction on the chemical, morphological, and thermal properties of the residual dewatered sludge (RDS). Lipid yields with unimodal distribution were observed across the particle size ranges (<0.5, 0.5–1.0, 1.0–2.0, 2.0–4.0, and 4.0 mm). The highest lipid yield of 1.95% was extracted from 1.0–2.0 mm after 4 h at 70 °C and 0.1 g/mL sludge-to-solvent ratio. Efficiency was influenced by the DS’s morphology, facilitating solvent infiltration and pore diffusion. The extraction process reduced water and organic fractions, resulting in higher thermal stability. Bibliometric analysis of “extraction*” and “sewage sludge” shows increasing research interest from 1973 to 2024. Five research clusters were observed: heavy metal speciation and stabilization, sludge and its bioavailability, extraction techniques and resource recovery, contaminants remediation, as well as phosphorus recovery and agricultural applications. These clusters highlight the diverse approaches to researching DS and RDS while promoting sustainable waste management. Full article

Despite the appealing properties of random copolymers, the use of these biomaterials in association with phospholipids is still limited, as several aspects of their performance have not been investigated. The aim of this work is the formulation of lipid/random copolymer platforms and the comprehensive study of their features by multiple advanced characterization techniques. Both biomaterials are amphiphilic, including two phospholipids (1,2-dioctadecanoyl-sn-glycero-3-phosphocholine (DSPC), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC)) and a statistical copolymer of oligo (ethylene glycol) methyl ether methacrylate (OEGMA) and 2-(diisopropylamino) ethyl methacrylate (DIPAEMA). We examined the design parameters, including the lipid composition, the % comonomer ratio, and the lipid-to-polymer ratio that could be critical for their behavior. The structures were also probed in different conditions. To the best of the authors’ knowledge, this is the first time that P(OEGMA-co-DIPAEMA)/lipid hybrid colloidal dispersions have been investigated from a membrane mechanics, biophysical, and morphological perspective. Among other parameters, the copolymer architecture and the hydrophilic to hydrophobic balance are deemed fundamental parameters for the biomaterial co-assembly, having an impact on the membrane’s fluidity, morphology, and thermodynamics. Exploiting their unique characteristics, the most promising candidates were utilized for methotrexate (MTX) loading to explore their encapsulation capability and potential antitumor efficacy in vitro in various cell lines. Full article

Ivermectin (IVM), a drug originally used for treating parasitic infections, is being explored for its potential applications in cancer therapy. Despite the promising anti-cancer effects of IVM, its low water solubility limits its bioavailability and, consequently, its biological efficacy as an oral formulation. To overcome this challenge, our research focused on developing IVM-loaded lipid polymer hybrid nanoparticles (LPHNPs) designed for potential pulmonary administration. IVM-loaded LPHNPs were developed using the emulsion solvent evaporation method and characterized in terms of particle size, morphology, entrapment efficiency, and release pattern. Solid phase characterization was investigated by Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and thermogravimetric analysis (TGA). Using a Twin stage impinger (TSI) attached to a device, aerosolization properties of the developed LPHNPs were studied at a flow rate of 60 L/min, and IVM was determined by a validated HPLC method. IVM-loaded LPHNPs demonstrated spherical-shaped particles between 302 and 350 nm. Developed formulations showed an entrapment efficiency between 68 and 80% and a sustained 50 to 60% IVM release pattern within 96 h. Carr’s index (CI), Hausner ratio (HR), and angle of repose (θ) indicated proper flowability of the fabricated LPHNPs. The in vitro aerosolization analysis revealed fine particle fractions (FPFs) ranging from 18.53% to 24.77%. This in vitro study demonstrates the potential of IVM-loaded LPHNPs as a delivery vehicle through the pulmonary route. Full article

Nanoparticles are structures that possess unique properties with high surface area-to-volume ratio. Their small size, up to 100 nm, and potential for surface modifications have enabled their use in a wide range of applications. Various factors influence the properties and applications of NPs, including the synthesis method and physical attributes such as size and shape. Additionally, the materials used in the synthesis of NPs are primary determinants of their application. Based on the chosen material, NPs are generally classified into three categories: organic, inorganic, and carbon-based. These categories include a variety of materials, such as proteins, polymers, metal ions, lipids and derivatives, magnetic minerals, and so on. Each material possesses unique attributes that influence the activity and application of the NPs. Consequently, certain NPs are typically used in particular areas because they possess higher efficiency along with tenable toxicity. Therefore, the classification and the base material in the NP synthesis hold significant importance in both NP research and application. In this paper, we discuss these classifications, exemplify most of the major materials, and categorize them according to their preferred area of application. This review provides an overall review of the materials, including their application, and toxicity. Full article

This research evaluated two methods of arginine encapsulation, melt emulsification and nanoprecipitation, using a lipid matrix of carnauba wax and commercial polymers (Eudragit^®) as a protective material. The ratios of wax–arginine were 1:1, 2:1, 3:1, and 4:1, while those of Eudragit^® RS:RL were 30:70 and 40:60 in proportions of 1:0.5 and 1:1 Eudragit^®–arginine. The microcapsules were morphostructurally characterized by scanning electron microscopy, and a microelement analysis was performed via energy-dispersive X-ray spectroscopy and Fourier transform infrared spectroscopy. Additionally, in vitro digestibility was used to determine the protection efficiency. Both encapsulated systems presented regular (crystals) and spherical (microcapsules) polyhedral morphologies. Qualitative nitrogen decreased significantly as the wax ratio increased in the wax–arginine formulations. The formulations with a 1:1 Eudragit:–arginine ratio (1000 mg arginine) produced a higher nitrogen content in the encapsulated systems than the formulations containing 500 mg of arginine. The 2:1 and 3:1 wax–arginine formulations had the lowest degradability after 5 h of rumen fluid exposure (40.7 and 21.26%, respectively) in comparison with 100% unencapsulated arginine. The 3:1 wax–arginine formulation is an efficient encapsulating system which protects against rumen degradation. The more intense absorption bands at 1738 cm⁻¹ and 1468 cm⁻¹ associated with the C=O and C-H groups in carnauba wax indicate that arginine was more protected than in the other systems. Full article